| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/35296086_HAS_TOPIC_C0001792> <https://research.tib.eu/covid-19/entity/35296086_HAS_TOPIC_C0021270> <https://research.tib.eu/covid-19/entity/35296086_HAS_TOPIC_C0042210> <https://research.tib.eu/covid-19/entity/35296086_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/35296086_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/35296086_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/35296086_HAS_TOPIC_C5387588> <https://research.tib.eu/covid-19/entity/35296086_HAS_TOPIC_C5392141> <https://research.tib.eu/covid-19/entity/35296086_HAS_TOPIC_C5398043>
?:authorAffiliation	[\'VITRO S.A., Granada, Spain.\', \'Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas (CSIC), Universidad Autónoma de Madrid, Madrid, Spain.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/%C3%81lvarez-Fern%C3%A1ndez_Stela> <https://research.tib.eu/covid-19/entity/Abia_David> <https://research.tib.eu/covid-19/entity/Alarc%C3%B3n_Balbino> <https://research.tib.eu/covid-19/entity/Delgado_Pilar> <https://research.tib.eu/covid-19/entity/Horndler_Lydia> <https://research.tib.eu/covid-19/entity/Olmo_Asunci%C3%B3n> <https://research.tib.eu/covid-19/entity/Quesada_Marina> <https://research.tib.eu/covid-19/entity/Romero-Pinedo_Salvador>
?:doi	10.3389/fimmu.2022.809285
?:doi	<https://research.tib.eu/covid-19/entity/10.3389/fimmu.2022.809285>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Research_Support%2C_Non-U.S._Gov%27t>
?:journal	Frontiers in immunology
is ?:pmid of	<https://research.tib.eu/covid-19/entity/35296086>
?:pmid	<https://research.tib.eu/covid-19/entity/35296086>
?:pmid	35296086
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	2.803
?:rankingScore_hIndex	69
?:title	Vaccine Type-, Age- and Past Infection-Dependence of the Humoral Response to SARS-CoV-2 Spike S Protein.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2022

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/35296086>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/35296086>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all